AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores a crucial clinical trial evaluating U-Petacitinib and L-Subrutinib for systemic lupus erythematosus. The discussion highlights the challenges in lupus trial design and the potential for these treatments to enhance patient outcomes in rheumatology.